Skip to content
2000
Volume 32, Issue 14
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

Actinic keratoses (AKs) are humans' most common keratinocyte-derived precancerous lesions. They can be observed predominantly in fair-skinned individuals on sun-exposed surfaces. Another name for AKs is solar keratosis. The primary risk factor for AKs is cumulative UV exposure from sunlight and/or tanning salons. AKs may present on a patient as a few detectable lesions. Clinically, they present as scaly erythema lesions with various pigmentations. Surgery treatment is the only approach that can definitively resolve the illness.

Methods

The research aims to demonstrate the effectiveness of treating relapsing AKs through the use of factors present during organogenesis extracted from zebrafish caviar conveyed through a cryopass therapy device (cryolaser phoresis). These factors are peptides present during specific phases of organogenesis and have shown the capacity to reverse cancer and neurodegeneration processes through gene, transcriptional, translational, and post-translational regulation.

Results

We found that 90% of patients responded. The percentage of responding patients was 100% among females and 80% among men.

Conclusion

Our results confirm previous findings about the effectiveness of stem cell differentiation stage factors (SCDFs) in cancer and open new ways to integrate treatment.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673289881240715172629
2024-07-19
2025-10-03

  • From This Site

    /content/journals/cmc/10.2174/0109298673289881240715172629
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. EinhornL. Are there factors preventing cancer development during embryonic life?Oncodev. Biol. Med.1983432192296298752
     [Google Scholar]
  2. LakshmiM.S. SherbetI. Embryonic and Tumor Cell Interactions; Sherbet, G.V. BaselK. New York, NY, USA1974380399
     [Google Scholar]
  3. BrentR.L. Radiation teratogenesis.Teratology198021328129810.1002/tera.14202103047006137
     [Google Scholar]
  4. PierceG.B. The cancer cell and its control by the embryo. Rous-whipple award lecture.Am. J. Pathol.198311311171246312802
     [Google Scholar]
  5. YuC.L. TsaiM.H. Fetal fetuin selectively induces apoptosis in cancer cell lines and shows anti-cancer activity in tumor animal models.Cancer Lett.2001166217318410.1016/S0304‑3835(01)00417‑711311490
     [Google Scholar]
  6. PapaioannouV.E. McBurneyM.W. GardnerR.L. EvansM.J. Fate of teratocarcinoma cells injected into early mouse embryos.Nature19752585530707310.1038/258070a01186881
     [Google Scholar]
  7. BiavaP. CanaiderS. FacchinF. BianconiE. LjungbergL. RotilioD. BuriganaF. VenturaC. Stem cell differentiation stage factors from zebrafish embryo: A novel strategy to modulate the fate of normal and pathological human (Stem) cells.Curr. Pharm. Biotechnol.201516978279210.2174/138920101666615062910282526201607
     [Google Scholar]
  8. VenturaC. CanaiderS. BianconiE. MaioliM. SantoroU. SantanielloS. BasoliV. BiavaP.M. VenturaC. Zebrafish embryo extract counteracts human stem cell senescence.Front. Biosci.20191118910410.2741/s52830844738
     [Google Scholar]
  9. FacchinF. BianconiE. CanaiderS. BasoliV. BiavaP.M. VenturaC. Tissue regeneration without stem cell transplantation: Self-healing potential from ancestral chemistry and physical energies.Stem Cells Int.201820181810.1155/2018/741203530057626
     [Google Scholar]
  10. FacchinF. AlvianoF. CanaiderS. BianconiE. RossiM. BonsiL. CasadeiR. BiavaP.M. VenturaC. Early developmental zebrafish embryo extract to modulate senescence in multisource human mesenchymal stem cells.Int. J. Mol. Sci.20192011264610.3390/ijms2011264631146388
     [Google Scholar]
  11. BiavaP.M. BonsignorioD. Cancer and cell differentiation: A model to explain malignancy.J. Tumor Marker Oncol.2002174754
     [Google Scholar]
  12. LaszloE. BiavaP.M. Information Medicine. The Revolutionary Cell-Reprogramming Discovery That Reverses Cancer and Degenerative Diseases.Healing Arts Press Rochester Vermont2019
     [Google Scholar]
  13. BiavaP.M. BonsignorioD. HoxaM. Cell proliferation curve od different human tumor lines after in vitro treatment with zebrafish embryonic extracts.J. Tumor Marker Oncol.2001163195202
     [Google Scholar]
  14. GardoniF. BelloneC. VivianiB. MarinovichM. MeliE. Pellegrini-GiampietroD.E. CattabeniF. Di LucaM. Lack of PSD-95 drives hippocampal neuronal cell death through activation of an αCaMKII transduction pathway.Eur. J. Neurosci.200216577778610.1046/j.1460‑9568.2002.02141.x12372013
     [Google Scholar]
  15. ProiettiS. CucinaA. PensottiA. BiavaP.M. MininiM. MontiN. CatizoneA. RicciG. LeonettiE. HarrathA.H. AlwaselS.H. BizzarriM. Active fraction from embryo fish extracts induces reversion of the malignant invasive phenotype in breast cancer through down-regulation of TCTP and modulation of E-cadherin/β-catenin pathway.Int. J. Mol. Sci.2019209215110.3390/ijms2009215131052313
     [Google Scholar]
  16. BiavaP.M. CiaurelliS. CipelliR.B. PisanoG. Stem cell differentiation stage factors (SCDSFs) taken from zebrafish embryo during organogenesis and their role as epigenetics regulators able to reverse neurosensory hearing loss.J. Otorhinolaryngol. Adv.202222303710.14302/issn.2379‑8572.joa‑22‑4072
     [Google Scholar]
  17. BiavaP.M. BonizzoniE. ZafiropouloS. LaudaniA. BuriganaF. Burian LissoiI. LottiT. Stem cell growth and differentiation factors from Zebrafish embryo and their role as epigenetic regulators in hair regeneration: results after transdermal administration using cryopass laser treatment.Aesthetic Medicine2020611119
     [Google Scholar]
  18. ArcelloniC. LanziR. PederciniS. High-performance liquid chromatographic determination of diclofenac in human plasma after solid-phase extraction.J. Chromatogr. B: Biomed. Sci. Appl.20017631-219520010.1016/S0378‑4347(01)00383‑8
     [Google Scholar]
  19. BaroliB. Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality?J. Pharm. Sci.2010991215010.1002/jps.2181719670463
     [Google Scholar]
  20. BensonH. Transdermal drug delivery: Penetration enhancement techniques.Curr. Drug Deliv.200521233310.2174/156720105277291516305405
     [Google Scholar]
  21. BhattacharyaS.S. BanerjeeS. GhoshA.K. ChattopadhyayP. VermaA. GhoshA. A RP-HPLC method for quantification of diclofenac sodium released from biological macromolecules.Int. J. Biol. Macromol.20135835435910.1016/j.ijbiomac.2013.03.06523567284
     [Google Scholar]
  22. BonizzoniE. Medical apparatus for cutaneous administration of medicaments.EP Patent 1752190A12007
  23. EscribanoE. CalpenaA.C. QueraltJ. ObachR. DoménechJ. Assessment of diclofenac permeation with different formulations: Anti-inflammatory study of a selected formula.Eur. J. Pharm. Sci.200319420321010.1016/S0928‑0987(03)00103‑912885384
     [Google Scholar]
  24. FluhrJ.W. FeingoldK.R. EliasP.M. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models.Exp. Dermatol.200615748349210.1111/j.1600‑0625.2006.00437.x16761956
     [Google Scholar]
  25. GallagherS.J. TrottetL. CarterT.P. HeardC.M. Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations.J. Drug Target.200311637337910.1080/1061186031000163689014668058
     [Google Scholar]
  26. GaurP.K. PurohitS. KumarY. MishraS. BhandariA. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery.Pharm. Dev. Technol.2014191485410.3109/10837450.2012.75140623281714
     [Google Scholar]
  27. KlimesJ SochorJ DolezalP KornerJ. HPLC evaluation of diclofenac in transdermal therapeutic preparations.Int. J. Pharm20012171-215316010.1016/S0378‑5173(01)00594‑4
     [Google Scholar]
  28. LeeW.R. ShenS.C. LaiH.H. HuC.H. FangJ.Y. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: A comparative study of lipophilic and hydrophilic drugs.J. Control. Release2001751-215516610.1016/S0168‑3659(01)00391‑111451505
     [Google Scholar]
  29. Leite-SilvaV.R. de AlmeidaM.M. FradinA. GriceJ.E. RobertsM.S. Delivery of drugs applied topically to the skin.Expert. Rev. Dermatol.20127438339710.1586/edm.12.32
     [Google Scholar]
  30. LopesP.S. PintoC.A.S.O. BabyA.R. VelascoM.V.R. TaquedaM.E. KanekoT.M. Evaluation of in vitro percutaneous enhancement effect of papain and pequi oil on diclofenac sodium permeation through human skin.RBCF Rev. Bras. Cienc. Farm.200844222523110.1590/S1516‑93322008000200008
     [Google Scholar]
  31. PatilU.K. SaraogiR. Natural products as potential drug permeation enhancer in transdermal drug delivery system.Arch. Dermatol. Res.2014306541942610.1007/s00403‑014‑1445‑y24481830
     [Google Scholar]
  32. SilvaJ.A. ApolinarioA.C. SouzaM.S.R. DamascenoB.P.G.L. MereidosA.C.D. Cutaneous drug delivery: Challenges and strategies for the development of transdermal formulations.Rev. Cienc. Farm. Basica Apl.2010313125131
     [Google Scholar]
  33. TerraneoL. FinatiE. VirgiliE. LNCaP prostate cancer growth in vivo: Oncostatic effects of melatonin as compared to hypoxia and reoxygenation.SPIESS, P.E., ed. Prostate cancer: Original scientific reports and case studiesRijeka: In Tech Europe20115779010.5772/26878
     [Google Scholar]
  34. TrommerH. NeubertR.H.H. Overcoming the stratum corneum: The modulation of skin penetration. A review.Skin Pharmacol. Physiol.200619210612110.1159/00009197816685150
     [Google Scholar]
  35. UNITED States Pharmacopeia: USP 35; National Formulary: NF 30.RockvilleUnited States Pharmacopeial Convention2013
     [Google Scholar]
  36. YilmazB. CiltasU. Determination of diclofenac in pharmaceutical preparations by voltammetry and gas chromatography methods.J. Pharm. Anal.20155315316010.1016/j.jpha.2014.10.00529403927
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673289881240715172629
Loading
Resolutive Treatment of Actinic Keratosis through Peptides Extracted from Zebrafish Conveyed Across Laser-assisted Transcutaneous Delivery (Cryopass Therapy)
Curr. Med. Chem. 32, 2767 (2025); https://doi.org/10.2174/0109298673289881240715172629
/content/journals/cmc/10.2174/0109298673289881240715172629
/content/journals/cmc/10.2174/0109298673289881240715172629
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): cancer; chromatography; cryopass laser; epigenentic; stem cell; Zebrafish embryo

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test